SCS Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.21M Sell
18,480
-754
-4% -$319K 0.07% 129
2026
Q1
$9.1M Sell
19,234
-40,948
-68% -$20.6M 0.1% 109
2025
Q4
$28.1M Sell
60,182
-7,821
-12% -$3.63M 0.3% 57
2025
Q3
$29M Sell
68,003
-177
-0.3% -$68.6K 0.32% 55
2025
Q2
$26.1M Buy
68,180
+39,524
+138% +$14.2M 0.29% 57
2025
Q1
$9.9M Buy
+28,656
New +$9.22M 0.13% 86

Other funds holding HCA

SCS Capital Management's HCA Position: Q2 2026 in Review

SCS Capital Management reduced its HCA Healthcare (HCA) stake by 3.9% in Q2 2026, selling an estimated $319K and leaving 18,480 shares worth $7.21M. The position accounts for 0.07% of the portfolio, ranked #129.

SCS Capital Management first reported a position in HCA in Q1 2025 and has held it in 6 quarters since. The position peaked at $29M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • SCS Capital Management held 18,480 shares of HCA Healthcare worth $7.21M as of Q2 2026.
  • SCS Capital Management sold 754 HCA Healthcare shares in Q2 2026, an estimated $319K.
  • HCA Healthcare made up 0.07% of SCS Capital Management's portfolio in Q2 2026, its #129 holding.
  • SCS Capital Management first reported a position in HCA Healthcare in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's HCA Healthcare position peaked at $29M in Q3 2025.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.